Douglas Conrad

468 total citations
8 papers, 320 citations indexed

About

Douglas Conrad is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Epidemiology. According to data from OpenAlex, Douglas Conrad has authored 8 papers receiving a total of 320 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pulmonary and Respiratory Medicine, 2 papers in Molecular Biology and 2 papers in Epidemiology. Recurrent topics in Douglas Conrad's work include Cystic Fibrosis Research Advances (5 papers), Respiratory viral infections research (2 papers) and Estrogen and related hormone effects (2 papers). Douglas Conrad is often cited by papers focused on Cystic Fibrosis Research Advances (5 papers), Respiratory viral infections research (2 papers) and Estrogen and related hormone effects (2 papers). Douglas Conrad collaborates with scholars based in United States, New Zealand and Germany. Douglas Conrad's co-authors include Paul B. Rainey, Merry Youle, Forest Rohwer, Matthew Haynes, Peter Salamon, Yan Wei Lim, Robert A. Quinn, Mike Furlan, Nicole Hanson and Dana Willner and has published in prestigious journals such as PLoS ONE, American Journal of Respiratory and Critical Care Medicine and The ISME Journal.

In The Last Decade

Douglas Conrad

8 papers receiving 315 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Douglas Conrad United States 8 168 151 71 53 36 8 320
Daniela Dolce Italy 10 170 1.0× 209 1.4× 45 0.6× 18 0.3× 53 1.5× 31 365
Lingdi Zhang United States 8 150 0.9× 62 0.4× 53 0.7× 19 0.4× 32 0.9× 19 321
Valerie J. Waters Canada 11 173 1.0× 368 2.4× 88 1.2× 24 0.5× 39 1.1× 15 487
Maryam Dadashi Iran 5 175 1.0× 123 0.8× 31 0.4× 21 0.4× 15 0.4× 10 343
Lucrecia Suárez Spain 9 129 0.8× 141 0.9× 32 0.5× 7 0.1× 30 0.8× 13 284
S. McGrath United Kingdom 6 179 1.1× 235 1.6× 61 0.9× 7 0.1× 30 0.8× 8 345
Mar Solé Spain 10 86 0.5× 72 0.5× 73 1.0× 19 0.4× 37 1.0× 10 445
Hendrik van Saene United Kingdom 2 159 0.9× 214 1.4× 46 0.6× 20 0.4× 18 0.5× 3 331
Rita Ziebach Germany 6 48 0.3× 84 0.6× 50 0.7× 27 0.5× 53 1.5× 6 229
Karin Wreiber Sweden 8 128 0.8× 63 0.4× 51 0.7× 9 0.2× 84 2.3× 9 434

Countries citing papers authored by Douglas Conrad

Since Specialization
Citations

This map shows the geographic impact of Douglas Conrad's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Douglas Conrad with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Douglas Conrad more than expected).

Fields of papers citing papers by Douglas Conrad

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Douglas Conrad. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Douglas Conrad. The network helps show where Douglas Conrad may publish in the future.

Co-authorship network of co-authors of Douglas Conrad

This figure shows the co-authorship network connecting the top 25 collaborators of Douglas Conrad. A scholar is included among the top collaborators of Douglas Conrad based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Douglas Conrad. Douglas Conrad is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Raghuvanshi, Ruma, Kerri A. Neugebauer, Douglas V. Guzior, et al.. (2022). Complex and unexpected outcomes of antibiotic therapy against a polymicrobial infection. The ISME Journal. 16(9). 2065–2075. 19 indexed citations
2.
King, P. A., Long Pham, R. T. Yamamoto, et al.. (2016). Longitudinal Metagenomic Analysis of Hospital Air Identifies Clinically Relevant Microbes. PLoS ONE. 11(8). e0160124–e0160124. 23 indexed citations
3.
Whiteson, Katrine, Barbara Bailey, Megan Bergkessel, et al.. (2014). The Upper Respiratory Tract as a Microbial Source for Pulmonary Infections in Cystic Fibrosis. Parallels from Island Biogeography. American Journal of Respiratory and Critical Care Medicine. 189(11). 1309–1315. 80 indexed citations
4.
Conrad, Douglas, Matthew Haynes, Peter Salamon, et al.. (2013). Cystic Fibrosis Therapy: A Community Ecology Perspective. American Journal of Respiratory Cell and Molecular Biology. 48(2). 150–156. 78 indexed citations
5.
Willner, Dana, Matthew Haynes, Mike Furlan, et al.. (2011). Case Studies of the Spatial Heterogeneity of DNA Viruses in the Cystic Fibrosis Lung. American Journal of Respiratory Cell and Molecular Biology. 46(2). 127–131. 79 indexed citations
6.
Ahlem, Clarence, Dominick L. Auci, Michael R. Kennedy, et al.. (2010). Novel components of the human metabolome: The identification, characterization and anti-inflammatory activity of two 5-androstene tetrols. Steroids. 76(1-2). 145–155. 16 indexed citations
7.
Conrad, Douglas, Angela Yee‐Moon Wang, Raymond Pieters, et al.. (2010). HE3286, an oral synthetic steroid, treats lung inflammation in mice without immune suppression. Journal of Inflammation. 7(1). 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026